Reported Standalone quarterly numbers for Sandu Pharmaceuticals are: Net Sales at Rs 17.70 crore in September 2024 up 6.61% from Rs. 16.61 crore in September 2023. Quarterly Net Profit at Rs. 0.50 crore in September 2024 down 9.34% from Rs. 0.55 crore in September 2023. EBITDA stands at Rs. 0.94 crore in September 2024 up 3.3% from Rs. 0.91 crore in September 2023.
Open FlipZomato Ltd., the food delivery aggregator, saw its shares advance on Monday (November 25) on the back of two triggers — 📌the company's inclusion in the 30-stock BSE Sensex and 📌an approval for its ₹8,500 crore Qualified Institutional Placement (QIP). Zomato is the first new-age tech stock that will replace JSW Steel in the BSE Sensex as part of the index reconstitution.
Open FlipShares of Paras Defence and Space Technologies hit 5 percent upper circuit at Rs 1,025 apiece on November 25 after it opened its advanced and state-of-the art optical systems testing facility in Navi Mumbai, Maharashtra. It is set to be the most advanced center for research and development of hyperspectral and other optical systems for space and defence in India.
Open Flip